EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark PRECIGEN was filed as Word mark on 09/11/2017 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/26/2018.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 017190273 |
| Application date | September 11, 2017 |
| Publication date | July 19, 2018 |
| Entry date | October 26, 2018 |
| Expiration date | September 11, 2027 |
Trademark owner
1872 Pratt Drive Suite 1400
24060 Blacksburg, VIRGINIA
US
24060 Blacksburg, VIRGINIA
US
Trademark representatives
Narvavägen 12
115 22 STOCKHOLM
SE
goods and services
1
Chemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; kits consisting primarily of proteins for regulating, modifying or restricting gene expression
5
Chemical preparations for medical and veterinary purposes; biochemical preparations for medical and veterinary purposes; chemical reagents for medical and veterinary purposes
42
Scientific research and development services; Development of products being genetic therapies, biopharmaceuticals, and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Research and development services for others in the fields of genetics and biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Healthcare research; Therapeutic research in the field areas including oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular disease; genetic engineering services; biopharmaceuticals services, namely, the design and construction of new biological parts, devices, and systems, and the redesign of existing, natural biological systems for useful purposes, recombinant gene engineering, and gene therapy services
44
Medical services; Healthcare services; Therapeutic services in the field areas including oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular disease
45
Technology transfer services, namely, licensing of intellectual property
ID: 11017190273